glp-1 colorectal cancer mortality study november 2025 In the weeks around the 2026 annual meeting of the American Society of Clinical Oncology, my phone kept buzzing with alerts about drugs and cancer. The headlines were everywhere – from GLP-1 receptor agonists show anti-cancer

There was no significant disparity in adverse reactions among the different preparations of GLP-1RA, among which the most common were gastrointestinal reactions, which mainly manifested as nausea, vomiting, and diarrhea

This cycling approach prevents receptor desensitization and maintains effectiveness across multiple cycles

Consult your healthcare provider before starting treatment

Managing cardiovascular risk in the post solid organ transplant recipient

The provider must first send the prescription to the pharmacy with the correct Bridge routing instructions

Abbreviations GLP-1 RAs: Glucagon-like peptide-1 receptor agonists T2DM: Type 2 diabetes mellitus COPD: Chronic obstructive pulmonary disease BMI: Body mass index HbA1c: Glycated hemoglobin RR: Relative risk CI: Confidence interval RCT: Randomized controlled trial CVOT: Cardiovascular outcome trial PRISMA: Preferred reporting items for systematic reviews and meta-analyses References Zar HJ, Ferkol TW